Fig. 2From: Efficacy and safety of artemether-lumefantrine and dihydroartemisinin-piperaquine for the treatment of uncomplicated Plasmodium falciparum malaria and prevalence of molecular markers associated with artemisinin and partner drug resistance in UgandaTrial profile, therapeutic efficacy study, Uganda, 2018–2019Back to article page